Bleeding Reduction in Grade II-III Haemorrhoids Through Embolization Treatment

BRIGHT is a Europe-wide study that will follow up to 250 adults with bleeding symptoms from haemmorhoids (Grade II-III categories). It aims to understand how well a minimally invasive procedure called haemorrhoid artery embolization (HAE) works in everyday clinical practice, which is a technique that blocks the blood vessels feeding the haemorrhoids. As this technique does not require major surgery, HAE offers several benefits such as less trauma, quicker recovery, and the use of only local anaesthesia.

NCT Number	NCT07264413
Lead Sponsor	Cardiovascular and Interventional Radiological Society of Europe Collaborators: Medtronic, Cook Group Incorporated
Conditions	Hemorrhoid, Hemorrhoid Bleeding
Enrollment	250 participants
Start Date	2026-08
Primary Completion	2030-04 (estimated)
Study Completion	2030-12 (estimated)
Updated on ClinicalTrials.gov	2026-07-02